Retroperitoneal relapse under post-orchiectomy surveillance in stage I testicular seminoma: A report of two cases

Haruki Kaku, Nobuyuki Kusaka, Takanori Murakami, Yasuo Yamamoto, Yoshiyuki Miyaji, Yasutomo Nasu, Tomoyasu Tsushima, Hiromi Kumon

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Although a low relapse rate and excellent survival are expected with our surveillance policy for stage I testicular seminoma, bulky relapse may occur in those patients who do not receive a regular follow-up. In such cases, aggressive chemotherapy is required. Two cases of retroperitoneal relapse under post-orchiectomy surveillance are herein reported. One patient had a bulky relapse and received 4 courses of BEP chemotherapy followed by retroperitoneal lymph node dissection. The other patient was treated with 3 courses of BEP chemotherapy. Although our surveillance policy is acceptable for stage I seminoma, we must keep in mind that bulky relapse is possible in those cases which receive irregular follow-up.

    Original languageEnglish
    Pages (from-to)463-465
    Number of pages3
    JournalNishinihon Journal of Urology
    Volume61
    Issue number5
    Publication statusPublished - May 1999

    Keywords

    • Lymph node
    • Seminoma
    • Stage I
    • Surveillance

    ASJC Scopus subject areas

    • Urology

    Fingerprint

    Dive into the research topics of 'Retroperitoneal relapse under post-orchiectomy surveillance in stage I testicular seminoma: A report of two cases'. Together they form a unique fingerprint.

    Cite this